LogoLogoLogoLogoLogo
  • Portfolio
  • News
    • In the News
    • Press Releases
  • Team
  • About Us
    • Our Approach
    • About McKesson
    • Contact Us
  • Portfolio
  • News
    • In the News
    • Press Releases
  • Team
  • About Us
    • Our Approach
    • About McKesson
    • Contact Us

Propeller Health Receives FDA Clearance to Connect Patients Using the Symbicort® Inhaler to its Digital Health Platform

...

Novartis receives CHMP positive opinion for Enerzair® Breezehaler® (QVM149), a potential first-in-class inhaled LABA/LAMA/ICS combination for uncontrolled asthma

When emissions decrease, people’s asthma gets better

Digital therapeutics company SidekickHealth inks partnership with Bayer

Express Scripts unveiled the first group of digital therapeutics included in its digital health formulary

Walgreens offers new tool for chronic care management

Inhaler Monitoring Cuts Hospitalization Usage, Study Finds

Propeller Health’s new deal with Orion Corporation extends its European reach

M&A Analysis: 10 Reasons Why ResMed Acquired Propeller Health for $225M

Asthma-related ER visits decline by more than half for patients using digitally connected inhalers

  • 1
  • 2
McKesson Ventures

One Post Street, 21st Floor
San Francisco, CA 94104
USA

Contact Us
Cookie Settings

 

In the News

  • RxLightning Closes $17.5M Series A to Accelerate Growth and Remove Barriers to Essential Specialty Medications

  • Aster Insights Announces that The University of Kansas Cancer Center will join the Oncology Research Information Network (ORIEN)

  • Inbound Health launches at-home post-surgery care

  • ‘A Startup Supporting Startups’: Inside Merck Digital Sciences Studio

Subscribe to Updates via Email

Enter your email address to subscribe to McKesson Ventures updates.

©2021 McKesson Ventures | Privacy Notice | Disclaimer
@McK_Ventures
McKesson Ventures LinkedIn